Go Pro
NASDAQ:DOMH

Dominari Q4 2024 Earnings Report

Dominari logo
$2.30 -0.15 (-6.12%)
Closing price 04:00 PM Eastern
Extended Trading
$2.28 -0.02 (-0.87%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Dominari EPS Results

Actual EPS
$0.20
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Dominari Revenue Results

Actual Revenue
$6.56 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Dominari Announcement Details

Quarter
Q4 2024
Time
During Market Hours
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Dominari's next earnings date is estimated for Thursday, November 5, 2026, based on past reporting schedules.

Conference Call Resources

Dominari Earnings Headlines

Dominari (NASDAQ:DOMH) Initiates Share Repurchase Program
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
Kyle Michael Wool Acquires 50,000 Shares of Dominari (NASDAQ:DOMH) Stock
See More Dominari Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Dominari? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Dominari and other key companies, straight to your email.

About Dominari

Dominari (NASDAQ:DOMH) is a diversified holding company that operates primarily through subsidiaries focused on financial services and investment activities. The company’s business includes securities brokerage, investment banking, wealth management and related capital-markets services.

Its principal operating platform, Dominari Securities LLC, is a U.S. broker-dealer that provides services to institutional and individual clients, including securities transactions, investment research, corporate finance and advisory support. The subsidiary operates within the regulatory framework applicable to broker-dealers and is a member of the Financial Industry Regulatory Authority and the Securities Investor Protection Corporation.

Dominari Holdings was formerly known as AIkido Pharma Inc. and adopted its current name as it transitioned away from its earlier biotechnology-focused operations toward financial services and investment management. The company is based in the United States and serves clients and investment opportunities primarily through its domestic financial-services operations.

View Dominari Profile